| Dr Paul Andrew Garfinkle, MD | |
|
985 S Sawburg Rd, Alliance, OH 44601-3515 | |
| (330) 823-1680 | |
| (330) 823-3831 |
| Full Name | Dr Paul Andrew Garfinkle |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 985 S Sawburg Rd, Alliance, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144297060 | NPI | - | NPPES |
| 2099812 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 75599 (Ohio) | Secondary |
| 207W00000X | Ophthalmology | 35075599G (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Surgical Hospital At Southwoods | Youngstown, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohio Eye Alliance, Inc. | 3173571809 | 4 |
News Archive
Anaphylaxis is a severe allergic reaction that can be life-threatening. Shellfish is the third most common food allergy to cause anaphylaxis.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.
An interview with Dr. Will Howat at SfN 2018, discussing the possibilities and challenges of immunohistochemistry (IHC) beyond a single color!
Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) – an international scientific society focused on research of dietary fats, oils and lipids.
› Verified 2 days ago
| Entity Name | Ohio Eye Alliance, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912974825 PECOS PAC ID: 3173571809 Enrollment ID: O20050110000050 |
News Archive
Anaphylaxis is a severe allergic reaction that can be life-threatening. Shellfish is the third most common food allergy to cause anaphylaxis.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.
An interview with Dr. Will Howat at SfN 2018, discussing the possibilities and challenges of immunohistochemistry (IHC) beyond a single color!
Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) – an international scientific society focused on research of dietary fats, oils and lipids.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Andrew Garfinkle, MD 985 S Sawburg Rd, Alliance, OH 44601-3515 Ph: (330) 823-1680 | Dr Paul Andrew Garfinkle, MD 985 S Sawburg Rd, Alliance, OH 44601-3515 Ph: (330) 823-1680 |
News Archive
Anaphylaxis is a severe allergic reaction that can be life-threatening. Shellfish is the third most common food allergy to cause anaphylaxis.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.
An interview with Dr. Will Howat at SfN 2018, discussing the possibilities and challenges of immunohistochemistry (IHC) beyond a single color!
Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) – an international scientific society focused on research of dietary fats, oils and lipids.
› Verified 2 days ago
Sanjeev Dewan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 985 S Sawburg Rd, Alliance, OH 44601 Phone: 330-823-1680 Fax: 330-823-3831 | |
Dr. Richard Aaron Lehrer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 985 S Sawburg Rd, Alliance, OH 44601 Phone: 330-823-1680 Fax: 330-823-3831 |